These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 21490128)

  • 21. Interplay of metabolism and transport in determining oral drug absorption and gut wall metabolism: a simulation assessment using the "Advanced Dissolution, Absorption, Metabolism (ADAM)" model.
    Darwich AS; Neuhoff S; Jamei M; Rostami-Hodjegan A
    Curr Drug Metab; 2010 Nov; 11(9):716-29. PubMed ID: 21189140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mibefradil is a P-glycoprotein substrate and a potent inhibitor of both P-glycoprotein and CYP3A in vitro.
    Wandel C; Kim RB; Guengerich FP; Wood AJ
    Drug Metab Dispos; 2000 Aug; 28(8):895-8. PubMed ID: 10901697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of an antiretroviral regimen containing ritonavir boosted lopinavir on intestinal and hepatic CYP3A, CYP2D6 and P-glycoprotein in HIV-infected patients.
    Wyen C; Fuhr U; Frank D; Aarnoutse RE; Klaassen T; Lazar A; Seeringer A; Doroshyenko O; Kirchheiner JC; Abdulrazik F; Schmeisser N; Lehmann C; Hein W; Schömig E; Burger DM; Fätkenheuer G; Jetter A
    Clin Pharmacol Ther; 2008 Jul; 84(1):75-82. PubMed ID: 18183034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro-in vivo correlation in P-glycoprotein mediated transport in intestinal absorption.
    del Amo EM; Heikkinen AT; Mönkkönen J
    Eur J Pharm Sci; 2009 Feb; 36(2-3):200-11. PubMed ID: 19063964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of tesmilifene, a substrate of CYP3A and an inhibitor of P-glycoprotein, on the pharmacokinetics of intravenous and oral docetaxel in rats.
    Choi YH; Suh JH; Lee JH; Cho IH; Lee MG
    J Pharm Pharmacol; 2010 Aug; 62(8):1084-8. PubMed ID: 20663044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The erythromycin breath test reflects P-glycoprotein function independently of cytochrome P450 3A activity.
    Kurnik D; Wood AJ; Wilkinson GR
    Clin Pharmacol Ther; 2006 Sep; 80(3):228-34. PubMed ID: 16952489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo modulation of intestinal CYP3A metabolism by P-glycoprotein: studies using the rat single-pass intestinal perfusion model.
    Cummins CL; Salphati L; Reid MJ; Benet LZ
    J Pharmacol Exp Ther; 2003 Apr; 305(1):306-14. PubMed ID: 12649383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gender has a small but statistically significant effect on clearance of CYP3A substrate drugs.
    Greenblatt DJ; von Moltke LL
    J Clin Pharmacol; 2008 Nov; 48(11):1350-5. PubMed ID: 18757784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intestinal drug transporter expression and the impact of grapefruit juice in humans.
    Glaeser H; Bailey DG; Dresser GK; Gregor JC; Schwarz UI; McGrath JS; Jolicoeur E; Lee W; Leake BF; Tirona RG; Kim RB
    Clin Pharmacol Ther; 2007 Mar; 81(3):362-70. PubMed ID: 17215845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced intestinal absorption of etoposide by self-microemulsifying drug delivery systems: roles of P-glycoprotein and cytochrome P450 3A inhibition.
    Zhao G; Huang J; Xue K; Si L; Li G
    Eur J Pharm Sci; 2013 Nov; 50(3-4):429-39. PubMed ID: 23981337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methodology for development of a physiological model incorporating CYP3A and P-glycoprotein for the prediction of intestinal drug absorption.
    Badhan R; Penny J; Galetin A; Houston JB
    J Pharm Sci; 2009 Jun; 98(6):2180-97. PubMed ID: 18855913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of oral ketoconazole on intestinal first-pass effect of midazolam and fexofenadine in cynomolgus monkeys.
    Ogasawara A; Kume T; Kazama E
    Drug Metab Dispos; 2007 Mar; 35(3):410-8. PubMed ID: 17142564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overlapping substrate specificities of cytochrome P450 3A and P-glycoprotein for a novel cysteine protease inhibitor.
    Zhang Y; Guo X; Lin ET; Benet LZ
    Drug Metab Dispos; 1998 Apr; 26(4):360-6. PubMed ID: 9531525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. P-glycoprotein plays a role in the oral absorption of BMS-387032, a potent cyclin-dependent kinase 2 inhibitor, in rats.
    Kamath AV; Chong S; Chang M; Marathe PH
    Cancer Chemother Pharmacol; 2005 Feb; 55(2):110-6. PubMed ID: 15338193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in pharmacokinetics of anti-HIV protease inhibitors during pregnancy: the role of CYP3A and P-glycoprotein.
    Mathias AA; Maggio-Price L; Lai Y; Gupta A; Unadkat JD
    J Pharmacol Exp Ther; 2006 Mar; 316(3):1202-9. PubMed ID: 16293714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of liver fibrosis on verapamil pharmacokinetics in rats.
    Chen M; Xu D; Hu XL; Wang H
    Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):287-94. PubMed ID: 17973928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interactions of pharmaceuticals and other xenobiotics on hepatic pregnane X receptor and cytochrome P450 3A signaling pathway in rainbow trout (Oncorhynchus mykiss).
    Wassmur B; Gräns J; Kling P; Celander MC
    Aquat Toxicol; 2010 Oct; 100(1):91-100. PubMed ID: 20719396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic interaction of cytochrome P450 3A-related compounds with rhodamine 123, a P-glycoprotein substrate, in rats pretreated with dexamethasone.
    Yumoto R; Murakami T; Sanemasa M; Nasu R; Nagai J; Takano M
    Drug Metab Dispos; 2001 Feb; 29(2):145-51. PubMed ID: 11159804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How important is intestinal cytochrome P450 3A metabolism?
    van Herwaarden AE; van Waterschoot RA; Schinkel AH
    Trends Pharmacol Sci; 2009 May; 30(5):223-7. PubMed ID: 19328560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional interactions between P-glycoprotein and CYP3A in drug metabolism.
    Christians U; Schmitz V; Haschke M
    Expert Opin Drug Metab Toxicol; 2005 Dec; 1(4):641-54. PubMed ID: 16863430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.